BCA
TMO icon

Bay Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bay Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Sell
410
-218
-35% -$105K 0.11% 104
2026
Q1 		$309K Sell
628
-39
-6% -$21.2K 0.19% 88
2025
Q4 		$386K Hold
667
– – 0.24% 75
2025
Q3 		$324K Hold
667
– – 0.21% 82
2025
Q2 		$270K Sell
667
-1
-0.1% -$418 0.21% 94
2025
Q1 		$332K Buy
668
+2
+0.3% +$1.08K 0.28% 79
2024
Q4 		$346K Buy
+666
New +$366K 0.28% 79

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Bay Capital Advisors's TMO Position: Q2 2026 in Review

Bay Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 35% in Q2 2026, selling an estimated $105K and leaving 410 shares worth $206K. The position accounts for 0.11% of the portfolio, ranked #104.

Bay Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $386K in Q4 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bay Capital Advisors held 410 shares of Thermo Fisher Scientific worth $206K as of Q2 2026.
  • Bay Capital Advisors sold 218 Thermo Fisher Scientific shares in Q2 2026, an estimated $105K.
  • Thermo Fisher Scientific made up 0.11% of Bay Capital Advisors's portfolio in Q2 2026, its #104 holding.
  • Bay Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Bay Capital Advisors's Thermo Fisher Scientific position peaked at $386K in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bay Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.